[Isolated left ventricular hypertrophy : is it a Fabry disease?].

Rev Med Suisse

Direction de la cardiologie, Département cœur-vaisseaux, CHUV, 1011 Lausanne.

Published: October 2020

Fabry disease, an X-linked disease, results from a deficiency of the lysosomal enzyme alpha-galactosidase A, which causes glycosphingolipids accumulation in the body. On the basis of the residual enzymatic activity level, a classical, severe multisystemic form and an attenuated cardiac variant form are distinguished. In all cases, patients can develop hypertrophic cardiomyopathy in adulthood, the severity of which is the leading cause of morbidity and mortality of the disease. The cardiomyopathy is usually isolated in the cardiac variant form, the most common form of the disease, and should be suspected in the presence of relatively specific ECG, echocardiographic and MRI characteristics.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cardiac variant
8
variant form
8
[isolated left
4
left ventricular
4
ventricular hypertrophy
4
hypertrophy fabry
4
fabry disease?]
4
disease?] fabry
4
disease
4
fabry disease
4

Similar Publications

Context: Congenital hypothyroidism (CH) is the most common neonatal endocrine disorder and is chiefly caused by thyroid dysgenesis (CHTD). The inheritance mode of the disease remains complex.

Objectives: Gain insight into the inheritance mode of CHTD.

View Article and Find Full Text PDF

Purpose Of Review: To summarize the available data on the use of immunosuppression therapies for the management of hot phases of disease and recurrent myocarditis in patients with desmoplakin cardiomyopathy (DSP-CMP).

Recent Findings: Occurrence of myocarditis episodes has been associated with worsening of outcomes in DSP-CMP. Multiple case reports and small case series have described potential benefit in using anti-inflammatory and immunosuppressive medications for the treatment of those episodes.

View Article and Find Full Text PDF

Background: While physical activity is found to be associated with a lower risk of dementia in numerous studies, less is known whether this association varies over time. We aim to examine the potential time-varying associations of physical activity with risk of dementia from midlife to late life.

Method: Participants aged 54 to 64 years of the Health Retirement Study (HRS) in 1996 were included.

View Article and Find Full Text PDF

Background: Glial fibrillary acidic protein (GFAP) is an astrocytic cytoskeletal protein and a promising blood biomarker for Alzheimer's disease (AD) and other neurodegenerative diseases. To date, the genetic architecture of plasma GFAP has not been characterized. We conducted a multi-ancestry meta-analyses of genome-wide association studies (GWAS) in diverse population-based cohorts to identify genetic variants associated with plasma levels of GFAP and to investigate their implication for neurological diseases.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

Background: Plasma p-tau217 shows high promise as an AD biomarker. In some mass spectrometry (MS) studies, the ratio between p-tau217 and the corresponding non-phospho peptide tau212-221 (p-tau217/T217) was suggested to increase accuracy to detect AD-type tau phosphorylation. However, disorders with rapid neurodegeneration or acute neuronal injury, are known to have increased neurodegeneration biomarkers e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!